Fulgent Genetics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Fulgent Genetics Inc.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
/ 
Frequently asked questions
To buy Fulgent Genetics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Fulgent Genetics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Fulgent Genetics Inc. is FLGT:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Fulgent Genetics Inc. has its primary listing on NASDAQ. You can trade Fulgent Genetics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Fulgent Genetics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Fulgent Genetics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Fulgent Genetics Inc..